These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24240726)

  • 1. Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy.
    Yang S; Yan HL; Tao QF; Yuan SX; Tang GN; Yang Y; Wang LL; Zhang YL; Sun SH; Zhou WP
    J Cancer Res Clin Oncol; 2014 Jan; 140(1):109-16. PubMed ID: 24240726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy.
    Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP
    Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin-43 can delay early recurrence and metastasis in patients with hepatitis B-related hepatocellular carcinoma and low serum alpha-fetoprotein after radical hepatectomy.
    Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
    BMC Cancer; 2013 Jun; 13():306. PubMed ID: 23800357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Villin 1 is a predictive factor for the recurrence of high serum alpha-fetoprotein-associated hepatocellular carcinoma after hepatectomy.
    Xieraili M; Yasen M; Mogushi K; Obulhasim G; Mayinuer A; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
    Cancer Sci; 2012 Aug; 103(8):1493-501. PubMed ID: 22530999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy.
    Tang J; Ou J; Xu C; Yi C; Xue F; Xu L; Lai F; Tang J; Li S; Kang T; Ding W; Wang B
    Oncol Rep; 2017 Oct; 38(4):2251-2258. PubMed ID: 28765910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
    J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma.
    Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L
    World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
    Ha SY; Song DH; Hwang SH; Cho SY; Park CK
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
    Wang YY; Qi LN; Zhong JH; Qin HG; Ye JZ; Lu SD; Ma L; Xiang BD; Li LQ; You XM
    Sci Rep; 2017 Feb; 7():42199. PubMed ID: 28181486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.
    Umeda S; Kanda M; Sugimoto H; Tanaka H; Hayashi M; Yamada S; Fujii T; Takami H; Niwa Y; Iwata N; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y
    BMC Cancer; 2017 Sep; 17(1):610. PubMed ID: 28863781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
    Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J
    Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
    Hu BS; Zhao G; Yu HF; Chen K; Dong JH; Tan JW
    Tumour Biol; 2013 Feb; 34(1):271-6. PubMed ID: 23055200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
    Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
    Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.